The drugstore chain also aims to lower capital expenditures by about $600 million, and expects to see the impact of the cost reductions begin by early next year, according to a
The plans set the stage for the arrival of new CEO
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.